Literature DB >> 25987323

Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate.

Fred W Reimherr1, Barrie K Marchant, Thomas E Gift, Tammy A Steans, Paul H Wender.   

Abstract

Much recent research describes the importance of emotional symptoms in ADHD. While there is no accepted system for including emotionality in diagnosing ADHD, the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) provides a tool to facilitate this. It assesses a range of adult ADHD symptoms which load on two factors: inattentive and emotional dysregulation. The consistently high inattentive factor was used to define significant elevation on the more variable emotional dysregulation factor (which contains four WRAADDS domains: hyperactivity/restlessness, temper, affective lability, and emotional over-reactivity) allowing the definition of two ADHD diagnostic types. We compared these two types on a broad range of adult subject characteristics, including response to methylphenidate (MPH) treatment assessed during two clinical trials. Marked impairment in three of the four emotional domains reflected a symptom severity level equivalent to that of the inattentive factor. 59 % met this threshold, defining them as ADHD emotion dysregulation presentation, as opposed to 41 % with ADHD inattentive presentation. Cluster analysis validated these groups by generating similar clusters with 85 % agreement regarding membership. ADHD emotional dysregulation presentation subjects showed more childhood ADHD symptoms, adult symptoms of oppositional defiant disorder, and evidence of personality disorder. Both types showed similar improvement during the double-blind MPH arm of the trials and during a 6-month open-label phase. Based on the presence of symptoms of emotional dysregulation, ADHD in adults can be conceptualized as two types. Impairment and comorbidity in adults with ADHD are largely concentrated in ADHD emotional dysregulation presentation patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25987323     DOI: 10.1007/s12402-015-0176-z

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  11 in total

1.  Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder.

Authors:  Annette Conzelmann; Eva Woidich; Ronald F Mucha; Peter Weyers; Mathias Müller; Klaus-Peter Lesch; Christian P Jacob; Paul Pauli
Journal:  J Neural Transm (Vienna)       Date:  2016-02-06       Impact factor: 3.575

2.  Predictors of Long-Term School-Based Behavioral Outcomes in the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Margot O Reed; Ewgeni Jakubovski; Jessica A Johnson; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-03-02       Impact factor: 2.576

Review 3.  Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Kim Boesen; Asger Sand Paludan-Müller; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

4.  ADHD symptoms in non-treatment seeking young adults: relationship with other forms of impulsivity.

Authors:  Samuel R Chamberlain; Konstantinos Ioannidis; Eric W Leppink; Faiza Niaz; Sarah A Redden; Jon E Grant
Journal:  CNS Spectr       Date:  2016-09-29       Impact factor: 3.790

5.  ADHD and Anxiety: Clinical Significance and Treatment Implications.

Authors:  Frederick W Reimherr; Barrie K Marchant; Thomas E Gift; Tammy A Steans
Journal:  Curr Psychiatry Rep       Date:  2017-11-20       Impact factor: 5.285

6.  Measuring the hierarchical general factor model of psychopathology in young adults.

Authors:  Benjamin B Lahey; David H Zald; Scott F Perkins; Victoria Villalta-Gil; Katherine B Werts; Carol A Van Hulle; Paul J Rathouz; Brooks Applegate; Quetzal A Class; Holly E Poore; Ashley L Watts; Irwin D Waldman
Journal:  Int J Methods Psychiatr Res       Date:  2017-10-08       Impact factor: 4.035

Review 7.  Adult ADHD and comorbid disorders: clinical implications of a dimensional approach.

Authors:  Martin A Katzman; Timothy S Bilkey; Pratap R Chokka; Angelo Fallu; Larry J Klassen
Journal:  BMC Psychiatry       Date:  2017-08-22       Impact factor: 3.630

8.  Clinical Trial of Efficacy Evaluation of Omega-3 with Risperidone on Seizures Frequency in Children with Refractory Epilepsy and Attention-Deficit/Hyperactivity Disorder.

Authors:  Razieh Fallah; Shiva Eiliaei; Farzad Ferdosian
Journal:  Iran J Child Neurol       Date:  2018

9.  Adult ADHD and emerging models of maladaptive personality: a meta-analytic review.

Authors:  Peter Jacobsson; Christopher J Hopwood; Bo Söderpalm; Thomas Nilsson
Journal:  BMC Psychiatry       Date:  2021-06-01       Impact factor: 3.630

10.  Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study.

Authors:  Alessandro Pallucchini; Marco Carli; Angelo G I Maremmani; Marco Scarselli; Giulio Perugi; Icro Maremmani
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.